文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

法国弯曲杆菌属菌血症回顾性多中心研究:弯曲杆菌菌血症研究

Retrospective Multicentric Study on Campylobacter spp. Bacteremia in France: The Campylobacteremia Study.
PubMed 文献 · Clin Infect Dis · 2022-01-01

这项法国37家医院5年回顾性多中心研究纳入592例弯曲杆菌属菌血症患者,发现以空肠弯曲杆菌和胎儿弯曲杆菌为主,患者多为老年免疫受损者,30天死亡率为11.7%,合适的抗生素治疗与30天生存独立相关(OR 0.47,95%CI 0.24-0.93,P=0.03)。

要点

  • 弯曲杆菌属菌血症主要发生于老年免疫受损患者,临床表现因菌种而异。
  • 合适的抗生素治疗与30天生存独立相关(OR 0.47,95%CI 0.24-0.93,P=0.03)。
  • 有效治疗启动中位延迟为2天(IQR 0-4天),对30天死亡率无显著影响(P=0.78)。

核心结论

  • 弯曲杆菌属菌血症主要发生于老年免疫受损个体,临床表现因菌种而异。
  • 合适的抗菌治疗与30天生存改善相关。

研究设计与样本

  • 法国37家参与国家弯曲杆菌和螺杆菌参考中心监测网络的医院开展的全法5年回顾性研究,纳入2015年1月1日至2019年12月31日诊断的弯曲杆菌属菌血症患者,共592例。

主要发现

  • 592例患者中,空肠弯曲杆菌和胎儿弯曲杆菌是最常见菌种(分别占42.9%和42.6%)。
  • 患者中位年龄68岁,多数有基础疾病,主要为免疫抑制(43.4%)、血液系统肿瘤(25.9%)、实体肿瘤(23%)和糖尿病(22.3%)。
  • 空肠弯曲杆菌和结肠弯曲杆菌与胃肠道体征相关,胎儿弯曲杆菌与继发定位感染相关。
  • 80例(13.5%)患者有继发定位感染,其中12例心内膜炎、38例血管感染、24例骨关节感染、9例腹水感染。
  • 30天死亡率为11.7%,合适的抗生素治疗与30天生存独立相关(OR 0.47,95%CI 0.24-0.93,P=0.03)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Campylobacter spp. bacteremia is a severe infection. A nationwide 5-year retrospective study was conducted to characterize its clinical features and prognostic factors. METHODS: The study included patients with Campylobacter spp. bacteremia diagnosed in 37 French hospitals participating in the surveillance network of the National Reference Center for Campylobacters and Helicobacters, from 1 January 2015 to 31 December 2019. The goal was to analyze the effects of a delay of appropriate antibiotic therapy and other risk factors on 30-day mortality rates, antibiotic resistance, patient characteristics, and prognosis according to the Campylobacter species. RESULTS: Among the 592 patients, Campylobacter jejuni and Campylobacter fetus were the most commonly identified species (in 42.9% and 42.6%, respectively). The patients were elderly (median age 68 years), and most had underlying conditions, mainly immunodepression (43.4%), hematologic cancers (25.9%), solid neoplasms (23%), and diabetes (22.3%). C. jejuni and Campylobacter coli were associated with gastrointestinal signs, and C. fetus was associated with secondary localizations. Among the 80 patients (13.5%) with secondary localizations, 12 had endocarditis, 38 vascular, 24 osteoarticular, and 9 ascitic fluid infections. The 30-day mortality rate was 11.7%, and an appropriate antibiotic treatment was independently associated with 30-day survival (odds ratio, 0.47 [95% confidence interval, .24-.93]; P = .03). The median efficient therapy initiation delay was quite short (2 days [interquartile range, 0-4 days]) but it had no significant impact on the 30-day mortality rate (P = .78). CONCLUSIONS: Campylobacter spp. bacteremia mainly occurred in elderly immunocompromised individuals with variable clinical presentations according to the species involved. Appropriate antimicrobial therapy was associated with improved 30-day survival.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Tinévez C, Velardo F, Ranc AG, et al. Retrospective Multicentric Study on Campylobacter spp. Bacteremia in France: The Campylobacteremia Study. Clin Infect Dis. 2022. PMID: 34849656. doi:10.1093/cid/ciab983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。